Comparative Assessment of QOL and Cognitive Function in Diabetic Drugs: Comparative Assessment of QOL and Cognitive Function - Softcover

K.C., Arulprakasam; Vijayakumar, P.R. Anand

 
9783659231087: Comparative Assessment of QOL and Cognitive Function in Diabetic Drugs: Comparative Assessment of QOL and Cognitive Function
Softcover
ISBN 10: 3659231088 ISBN 13: 9783659231087
Verlag: LAP LAMBERT Academic Publishing, 2012

Inhaltsangabe

Diabetes mellitus has become a major cause of illness and disability across the world. The number of people with diabetes is increasing due to population growth, aging, urbanization, and increasing prevalence of obesity and physical inactivity. Quantifying the prevalence of diabetes and the number of people affected by diabetes now and in the future is important to allow rational planning and allocation of resources. Epidemiological data for India indicates that people affected by diabetes in India presently are about 31,196,000 and projections for 2030 in India are about 79,441,000 as reported in the World Health Organization [WHO] Global Burden of Disease Study. The present work discusses the importance of the antidiabetic therapies in altering the Quality of Life and cognitive parameters in diabetic conditions. The outcome of the study will measure the efficacy of antidiabetic drug on quality of life and cognitive function of the diabetic patients. The comparative efficacy of the antidiabetic drugs used in the treatment of diabetic patients in relation to Sociodemographic and lifestyle characteristics on their Quality of Life and cognitive paradigms will also be revealed.

Die Inhaltsangabe kann sich auf eine andere Ausgabe dieses Titels beziehen.

Reseña del editor

Diabetes mellitus has become a major cause of illness and disability across the world. The number of people with diabetes is increasing due to population growth, aging, urbanization, and increasing prevalence of obesity and physical inactivity. Quantifying the prevalence of diabetes and the number of people affected by diabetes now and in the future is important to allow rational planning and allocation of resources. Epidemiological data for India indicates that people affected by diabetes in India presently are about 31,196,000 and projections for 2030 in India are about 79,441,000 as reported in the World Health Organization [WHO] Global Burden of Disease Study. The present work discusses the importance of the antidiabetic therapies in altering the Quality of Life and cognitive parameters in diabetic conditions. The outcome of the study will measure the efficacy of antidiabetic drug on quality of life and cognitive function of the diabetic patients. The comparative efficacy of the antidiabetic drugs used in the treatment of diabetic patients in relation to Sociodemographic and lifestyle characteristics on their Quality of Life and cognitive paradigms will also be revealed.

Biografía del autor

Arul Prakasam K.C.M.Pharm., Department of pharmacy practice,JSS College of Pharmacy,OOTY,Tamil Nadu, India

„Über diesen Titel“ kann sich auf eine andere Ausgabe dieses Titels beziehen.

Verlag
LAP LAMBERT Academic Publishing
Erscheinungsdatum
2012
Sprache
Englisch
ISBN 10 
3659231088
ISBN 13 
9783659231087
Einband
Tapa blanda
Anzahl der Seiten
76
Kontakt zum Hersteller
Nicht verfügbar
Verantwortliche Person
Nicht verfügbar